Opus Genetics (IRD) EPS (Weighted Average and Diluted) (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -257.14% |
| Dec 31, 2025 | 16.00% |
| Sep 30, 2025 | -108.33% |
| Jun 30, 2025 | 50.00% |
| Mar 31, 2025 | 81.10% |
| Dec 31, 2024 | -337.93% |
| Sep 30, 2024 | 3.33% |
| Jun 30, 2024 | -3.45% |
| Mar 31, 2024 | -38.10% |
| Dec 31, 2023 | -184.00% |
| Sep 30, 2023 | 204.17% |
| Jun 30, 2023 | 14.29% |
| Mar 31, 2023 | -116.57% |
| Dec 31, 2022 | 868.18% |
| Sep 30, 2022 | 12.00% |
| Jun 30, 2022 | 28.57% |
| Mar 31, 2022 | -94.44% |
| Dec 31, 2021 | 28.00% |
| Sep 30, 2021 | 51.92% |
| Jun 30, 2021 | 85.43% |
| Mar 31, 2021 | 2.72% |
| Dec 31, 2020 | -1,012.12% |
| Sep 30, 2020 | 23.26% |
| Jun 30, 2020 | 50.57% |
| Dec 31, 2017 | -200.00% |
| Sep 30, 2017 | -233.33% |
| Jun 30, 2017 | 103.30% |